Sex Differences of Longitudinal Brain Changes in Cognitively Unimpaired Adults

J Alzheimers Dis. 2020;76(4):1413-1422. doi: 10.3233/JAD-200293.

Abstract

Background: There is increasing evidence that AD progression differs by sex.

Objective: The aim of this work was to determine sex differences in the association of baseline levels of cerebrospinal fluid (CSF) biomarkers (Aβ42, p-tau, YKL-40, sTREM2) with longitudinal brain changes in cognitively unimpaired (CU) older adults.

Methods: This pilot study included 36 CU subjects (age 66.5±5.5, 12 male) scanned twice, two years apart. Using a voxel-wise analysis, we determined the sex differences in the association maps between CSF biomarkers and atrophy rates.

Results: We did not find differences related to Aβ42. We found a greater impact of the rest of CSF biomarkers in areas of the Papez circuit in women versus men. Men showed greater involvement in lateral parietal and paracentral areas.

Discussion: Results suggest an early differential progression of brain atrophy between sexes. Further research will elucidate whether the mechanisms responsible for sex-specific atrophy patterns are biological and/or environmental.

Keywords: Cerebrospinal fluid biomarkers; YKL-40; cognitively unimpaired older adults; longitudinal VBM; sTREM2; sex differences.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / pathology
  • Amyloid beta-Peptides / cerebrospinal fluid*
  • Atrophy
  • Biomarkers / cerebrospinal fluid
  • Brain / metabolism
  • Brain / pathology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Peptide Fragments / cerebrospinal fluid
  • Pilot Projects
  • Sex Characteristics
  • tau Proteins / cerebrospinal fluid*

Substances

  • Amyloid beta-Peptides
  • Biomarkers
  • Peptide Fragments
  • tau Proteins